Rosales-Sánchez I, Martínez-Hernández P, Rosas-Torres L, Jiménez-Díaz F, Gutiérrez-Belmont IJ, Gutiérrez- Hernández JA

Language: Spanish
References: 8
Page: 341-347
PDF size: 323.78 Kb.

ABSTRACT

With the increasing development of medical specialties, an urgent necessity of parallel specialties in the laboratories and nursing fields becomes evident. Immunology is the field of science responsible for the study of defense responses developed by an individual in the face of aggression by microorganisms or foreign particles as well as those coming from the internal environment such as neoplastic cells.1 Immunology is considered as a young discipline with an spectacular development that took place in the second half of 20th century. From then till date, there have been many important spectacular advances in the area leading to its consolidation as an independent science separate from microbiology. As part of the Immunology Service at the Instituto Nacional de Pediatria (INP), the Short-Stay Immunotherapy Unity (SSI) was established. This unity has been fundamental in ensuring adequate treatment for patients with primary immunodeficiency and autoimmune in the long term. We highlight the roles of the nursing staff of SSI in the area of drug preparation and patient care.

REFERENCES

1. Berrón PR, Espinosa RF, Márquez AM, Sainos RA, Marfil RJ, Selva PJ et al. Consenso de expertos en el uso terapéutico actual de la inmunoglobulina intravenosa. Rev Alerg Méx. 2005;52:42-50.

2. Rodríguez RN, Tallet VL. Mecanismos de acción de la gammaglobulina para uso endovenoso. Rev Cubana Hematol Inmnuol Hemoter. 2002;18:4-7.

3. Fichas técnicas de los diferentes productos encontrados en México.

4. Contreras MA, Pereira ME. Terapia con inmunoglobulina endovenosa. Rev Chil Reumatol. 2009;25:124-129.

5. Montoya GC, Sorensen RU. Lecciones sobre el uso de gammaglobulina humana endovenosa. Boletín LAGID. 2001. Disponible en http://www.lagid.lsuhsc.edu/Tratamientos/971-010. htm. Consultado el 06/06/13.

6. Gardulf AL, Nicolay UP, Asensio OB, Bernatowska EC. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114:936-942.

7. Kittner JM, Schmidt RE, Wulff WN, Jäger BJ. Patients attitude to subcutaneous immunoglobulin substitution as home therapy. J Clin Immunol. 2006;26:400-405.

8. Lednik LA, Baker MT, Sullivan KJ, Poynter MC, O Quinn LE, Smith CB. Subcutaneous immunoglobulin therapy. Is selfadministration of safe in a home care setting? Home Healthc Nurse. 2013;31:134-141.